Monopar Therapeutics Statistics

Total Valuation

MNPR has a market cap or net worth of $193.95 million. The enterprise value is $139.40 million.

Market Cap	193.95M
Enterprise Value	139.40M

Important Dates

The last earnings date was Tuesday, May 13, 2025, before market open.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

MNPR has 6.11 million shares outstanding. The number of shares has increased by 62.90% in one year.

Current Share Class	6.11M
Shares Outstanding	6.11M
Shares Change (YoY)	+62.90%
Shares Change (QoQ)	+42.52%
Owned by Insiders (%)	4.60%
Owned by Institutions (%)	29.10%
Float	2.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.62
P/TBV Ratio	3.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 36.92

Current Ratio	36.92
Quick Ratio	36.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.27% and return on invested capital (ROIC) is -36.15%.

Return on Equity (ROE)	-54.27%
Return on Assets (ROA)	-34.49%
Return on Invested Capital (ROIC)	-36.15%
Return on Capital Employed (ROCE)	-32.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.04M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +920.32% in the last 52 weeks. The beta is 1.13, so MNPR's price volatility has been higher than the market average.

Beta (5Y)	1.13
52-Week Price Change	+920.32%
50-Day Moving Average	37.76
200-Day Moving Average	24.61
Relative Strength Index (RSI)	37.11
Average Volume (20 Days)	17,940

Short Selling Information

The latest short interest is 38,031, so 0.62% of the outstanding shares have been sold short.

Short Interest	38,031
Short Previous Month	44,062
Short % of Shares Out	0.62%
Short % of Float	1.31%
Short Ratio (days to cover)	2.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-17.66M
Pretax Income	-7.12M
Net Income	-16.57M
EBITDA	n/a
EBIT	-17.66M
Earnings Per Share (EPS)	-$3.51

Full Income Statement

Balance Sheet

The company has $54.55 million in cash and n/a in debt, giving a net cash position of $54.55 million or $8.92 per share.

Cash & Cash Equivalents	54.55M
Total Debt	n/a
Net Cash	54.55M
Net Cash Per Share	$8.92
Equity (Book Value)	53.59M
Book Value Per Share	8.76
Working Capital	53.58M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-10.41M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-62.90%
Shareholder Yield	-62.90%
Earnings Yield	-8.54%
FCF Yield	n/a

Analyst Forecast

The average price target for MNPR is $59.50, which is 88.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$59.50
Price Target Difference	88.11%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 13, 2024. It was a reverse split with a ratio of 0.2:1.

Last Split Date	Aug 13, 2024
Split Type	Reverse
Split Ratio	0.2:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2